HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.

Natural killer (NK) cells recognize alloantigens on normal cells. One of these alloantigens correlates with homozygosity for a dimorphism of HLA-C at positions 77-80, which is shared by a number of HLA-C alleles. A second allelic alloantigen correlates with homozygosity for the alternative HLA-C dimorphism, which is shared by the remaining HLA-C alleles. Moreover, NK1- and NK2-specific NK cell lines can be generated by mixed leukocyte cultures in which donor and stimulator are homozygous for the alternative dimorphisms at positions 77-80 of HLA-C. In the present work, the role of HLA-C in NK cell-mediated allorecognition was directly investigated by analyzing the effects produced by transfection of several HLA-C alleles on NK sensitivity of class I-deleted mutant cell lines. Transfection of cells with HLA-C alleles encoding Asn-77-Lys-80 (including HLA-Cw4, -Cw5, and -Cw6) inhibited the lysis of the targets by NK1-specific NK cells, whereas HLA-C alleles encoding Ser-77-Asn-80 (including HLA-Cw1, -Cw7, and -Cw13) protected the targets from NK2-specific NK cells. Thus, HLA-C alleles are the dominant inhibitory ligands that protect targets from lysis by these allospecific NK cells.

[1]  V. Gnau,et al.  Allele-specific peptide ligand motifs of HLA-C molecules. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Klein,et al.  Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with β2‐microglobulin , 1993, European journal of immunology.

[3]  K. Lewis,et al.  In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation. , 1993, Journal of immunology.

[4]  E. Brooks,et al.  Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. , 1993, Science.

[5]  J. Bodmer,et al.  Nomenclature for Factors of the HLA System, 1991 , 1992, Immunobiology.

[6]  W. Seaman,et al.  The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. , 1993, Annual review of immunology.

[7]  S. Sambhara,et al.  Effect of class I MHC binding peptides on recognition by natural killer cells. , 1992, Journal of immunology.

[8]  P. Nelson,et al.  Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides. , 1992, Journal of immunology.

[9]  A. Amoroso,et al.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) , 1992, The Journal of experimental medicine.

[10]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[11]  J. Strominger,et al.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Cresswell,et al.  Peptide-induced modulation of target cell sensitivity to natural killing. , 1992, Journal of immunology.

[13]  W. Yokoyama,et al.  MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.

[14]  P. Parham,et al.  The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. , 1992, Journal of immunology.

[15]  D. Schendel,et al.  Isolation and characterization of a genomic HLA-Cw6 clone. , 1992, Tissue antigens.

[16]  J. Guardiola,et al.  Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans , 1992, The Journal of experimental medicine.

[17]  P. Parham,et al.  Molecular definition of a polymorphic antigen (LA45) of free HLA-A and - B heavy chains found on the surfaces of activated B and T cells , 1991, The Journal of experimental medicine.

[18]  Eric O Long,et al.  Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. , 1991, Human immunology.

[19]  P. Cresswell,et al.  Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Lopalco,et al.  Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains , 1991, The Journal of experimental medicine.

[21]  K. Rock,et al.  Dissociation of β 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface , 1991, Cell.

[22]  D. R. Lee,et al.  The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure , 1991, The Journal of experimental medicine.

[23]  M. Colonna,et al.  Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Storkus,et al.  Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules. , 1991, Critical reviews in immunology.

[25]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[26]  R. Pardi,et al.  T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Pardi,et al.  Natural killer lines and clones with apparent antigen specificity , 1990, The Journal of experimental medicine.

[28]  J. Guardiola,et al.  Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells , 1990, The Journal of experimental medicine.

[29]  O. Majdic,et al.  Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin , 1990, The Journal of experimental medicine.

[30]  M. Smith,et al.  The conformational flexibility of class I H-2 molecules as revealed by anti-peptide antibodies specific for intracytoplasmic determinants: differential reactivity of beta 2-microglobulin "bound" and "free" H-2Kb heavy chains. , 1990, Molecular immunology.

[31]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[32]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[33]  R. Demars,et al.  Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. Implications for the control of expression and immunogenicity of HLA-C antigens. , 1989, Journal of immunology.

[34]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[35]  Eric O Long,et al.  Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture , 1988, The Journal of experimental medicine.

[36]  J. Gnarra,et al.  Possible association between IL-2 receptors and class I HLA molecules on T cells. , 1988, Journal of immunology.

[37]  S. Demaria,et al.  Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Ploegh,et al.  Allele and locus‐specific differences in cell surface expression and the association of HLA class I heavy chain with β2‐microglobulin: differential effects of inhibition of glycosylation on class I subunit association , 1988, European journal of immunology.

[39]  P. Cresswell,et al.  NK susceptibility varies inversely with target cell class I HLA antigen expression. , 1987, Journal of immunology.

[40]  M. Samson,et al.  Cross-linking of insulin receptors to MHC antigens in human B lymphocytes: evidence for selective molecular interactions. , 1986, Journal of immunology.

[41]  H. Ploegh,et al.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.

[42]  M. Simonsen,et al.  The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Strachan,et al.  Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA‐CW3). , 1984, The EMBO journal.

[44]  J. Schlessinger,et al.  Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells , 1984, The Journal of cell biology.

[45]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[46]  C. Barnstable,et al.  Molecular structure of human histocompatibility antigens: the HLA‐C series , 1977, European journal of immunology.